F389-0746

N/A

Report date: 2023/01/31 14:34:02
NME

Base Information

Drug NameF389-0746
Drug Alias NameF-389-0746F389-0746
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 4 inhibitors
TargetsMitogen-activated protein kinase kinase kinase kinase 4
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaipei Medical University
China Registration ClassN/A

Develop Information

Active CompaniesTaipei Medical University
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A